Stocks to sell

Three years ago, I warned against buying stock in Nio (NYSE:NIO), the Chinese luxury electric vehicle (EV) maker.  At the time, the stock was selling at $6 per share.

Source: Robert Way / Shutterstock.com

I was wrong.

Two years ago, as the Covid-19 pandemic began, China’s government put a floor under the NIO stock price. It provided state subsidies and manufacturing through JAC Motors.

Shares rose from under $5 to over $60 by early 2021. Even in November 2020, however, I was warning about Nio becoming a bubble stock. My Investorplace.com colleague Will Ashworth agreed two months later.

Will called the top. As the stock price fell, I resumed my call to avoid it.

Nio opens Mar. 2, 2022 at around $22 per share. That is a market cap of $35.7 billion on expected 2021 sales of $5.2 billion. Electric cars are great; luxury electric cars are great, but is Nio headed back to $60 or back below $6?

Paper Dragon

Despite what you may be reading about China’s enormous power, it is a paper dragon.

China’s economy grew 8.1% in 2021, but only by 2.1% in 2020. It is falling below government projections and growth is slowing down.

General Secretary Xi Jinping’s movement against tech companies like Alibaba Group Holding (NYSE:BABA) has turned into a fight against wealth itself. Ostentatious displays of wealth are out, even among the middle class. Cruising hasn’t returned. In the gambling mecca of Macau, the situation is grim. 

Nio’s bailout changed the profile of its buyers. Forget the millennial wanting to pick up girls and enter the party apparatchik wanting to display his power. Meanwhile, Goldman Sachs (NYSE:GS) was endorsing the changes I warned readers about.

China’s electric car market is growing rapidly. But as it expands, its profile is changing. Luxury sedans are a niche market. The big sales are in cars like the Wuling Hongguang Mini, which cost just $4,500. Nio isn’t among the top 15 sellers in its home market.

Exports Won’t Solve It

Nio is being celebrated for its quick battery swap-outs. It will list in both Hong Kong and Singapore to avoid the sting of anti-China Americans. It even has boosters here at InvestorPlace, who like its delivery numbers and new models.

But Nio will need exports to drive growth. It is not among the top 5 Chinese exporters. No JAC Motors brand is.

Nio has said it plans a “Norway model.” That means it is going after savvy buyers and focusing on the total ownership experience. Total deliveries to Norway over two years are expected to be 7,000.

But to achieve success, Nio needs infrastructure. Not just charging infrastructure, but service and especially battery swaps. Such things cost money. Nio still had $7.3 billion in cash and cash equivalents at the end of September, according to its quarterly report. But it still lost $132 million in the third quarter, 5.8% of sales. The numbers are better than they might be because the Chinese Yuan continues to appreciate, from 6.6 to the dollar a year ago to 6.2 now.

The Bottom Line on NIO Stock

Nio is a niche product in China. It will be a niche product in other markets. Nio still isn’t making money.

Nio is sometimes called the “Chinese Tesla” (NASDAQ:TSLA). But Tesla is beating it badly in its home market. Tesla has its own Chinese factory. Nio does not.

Growth can look good from a small base. Nio hopes to break even for the fourth quarter, which will be reported on Mar. 24. But to achieve that result, it is cutting growth. Sales were $1.53 billion in the third quarter and are expected to be $1.67 billion in the fourth.

When someone brings out an electric car that a middle class family can afford, I will gladly consider its stock. Nio is not that company.

On the date of publication, Dana Blankenhorn held a long position in BABA. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Articles You May Like

Top Wall Street analysts like these dividend-paying stocks
Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally
Goldman Sachs: Why individual investors need to look at private investments to further grow wealth
Hedge funds performed better under Democratic presidents than Republican ones, history shows
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value